Zavzpret — United Healthcare
acute treatment of migraine
Initial criteria
- Diagnosis of migraine headaches with or without aura
- Used for acute treatment of migraine
- Medication will not be used in combination with another acute calcitonin gene-related peptide receptor (CGRP) antagonist (e.g. Nurtec ODT)
Reauthorization criteria
- Documentation of positive clinical response to therapy
- Medication will not be used in combination with another acute calcitonin gene-related peptide receptor (CGRP) antagonist (e.g. Nurtec ODT)
Approval duration
12 months